Rapid detection method for avian metapneumovirus based on CRISPR-Cas13a system

Through the rapid detection method based on the CRISPR-Cas13a system, using specific primer groups and crRNA sequences, combined with LwaCas13a protein and other components, the problems of long detection time of avian metapneumovirus and equipment dependence in the existing technology are solved, and efficient and rapid , nucleic acid molecular detection of metapneumovirus of avian metapneumovirus is suitable for grassroots and on-site applications.

CN119082372AActive Publication Date: 2024-12-06GUANGXI UNIV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411428389.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-14
Publication Date
2024-12-06
Estimated Expiration
2044-10-14

AI Technical Summary

Technical Problem

The existing avian metapneumovirus detection methods have long detection time, cumbersome steps, high cost, and dependence on professional and technical personnel and specific instruments and equipment, making them difficult to be applicable to rapid clinical testing.

Method used

Using a rapid detection method based on the CRISPR-Cas13a system, using specific primer sets and crRNA sequences, combined with LwaCas13a protein, fluorescent RNA reporter, T7 RNA polymerase, NTP mix and buffer, the CRISPR-Cas13a reaction system was amplified by constant temperature. Conduct inspection, simple operation and no dependence on professional equipment.

Benefits of technology

It realizes efficient, fast and specific detection of nucleic acid molecules of avian metapneumovirus, with a sensitivity of 2 copies, suitable for grassroots and on-site applications, and provides accurate determination of early infection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082372A_ABST
    Figure CN119082372A_ABST
Patent Text Reader

Abstract

The invention discloses an avian metapneumovirus rapid detection method based on a CRISPR-Cas13a system, relates to the technical field of avian disease detection, and more specifically discloses a primer group for detecting the avian metapneumovirus based on the CRISPR-Cas13a system, and the primer group comprises an isothermal amplification primer pair and a crRNA sequence. The detection method disclosed by the invention can specifically detect the avian metapneumovirus, has the sensitivity of 2 copies, has the advantages of good specificity, high sensitivity, good repeatability, simplicity and rapidness in operation, no dependence on professional technicians and specific instruments and equipment and the like, is suitable for base-level and field application, can rapidly detect nucleic acid molecules of the avian metapneumovirus, and has wide application prospects. And an efficient and accurate detection method is provided for judging early infection of the avian metapneumovirus in production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of poultry disease detection, and more specifically to a method for rapid detection of avian metapneumovirus based on a CRISPR-Cas13a system. Background Art

[0002] Avian Metapneumovirus (aMPV) belongs to the Paramyxoviridae, Pneumovirinae, and Metapneumovirus genus. Turkeys, chickens, and ducks of different ages can be infected with aMPV. Poultry infection with aMPV is often accompanied by secondary infections, such as Escherichia coli infection, which can cause swollen head syndrome and a series of neurological symptoms, such as torticollis and opisthotonos. In addition, aMPV can proliferate in the reproductive and urinary tract tissues, leading to the degeneration of the oviducts and ovaries of breeder chickens, causing a decrease in egg production and the production of deformed eggs, which brings great harm to the poultry industry.

[0003] At present, the main molecular biological detection methods for aMPV are RT-PCR and real-time fluorescence quantitative PCR. However, the above methods have the disadvantages of long detection time, complicated steps, high cost, reliance on professional technicians and specific instruments and equipment, and high requirements for the detection environment, making them unsuitable for clinical field testing.

[0004] Therefore, developing a method that does not rely on expensive detection equipment and can achieve efficient, rapid, and on-site detection of avian metapneumovirus is an urgent problem that technicians in this field need to solve. Summary of the invention

[0005] In view of this, the present invention provides a method for rapid detection of avian metapneumovirus based on the CRISPR-Cas13a system. The method has the advantages of good specificity, high sensitivity, good repeatability, simple and rapid operation, and no reliance on professional technicians and specific instruments and equipment. It is suitable for grassroots and on-site applications, and can quickly detect avian metapneumovirus nucleic acid molecules, providing an efficient and accurate detection method for determining early infection of avian metapneumovirus in production.

[0006] In order to achieve the above object, the present invention adopts the following technical solution:

[0007] A primer set for detecting avian metapneumovirus based on the CRISPR-Cas13a system, the primer set comprising a constant temperature amplification primer pair and a crRNA sequence;

[0008] Furthermore, the nucleotide sequence of the isothermal amplification primer pair is shown as SEQ ID NO.3 and SEQ ID NO.5, and the nucleotide sequence of the crRNA sequence is shown as SEQ ID NO.11.

[0009] Another object of the present invention is to provide a kit for detecting avian metapneumovirus based on the CRISPR-Cas13a system, wherein the kit comprises the above-mentioned primer set.

[0010] Preferably, the kit further comprises LwaCas13a protein, fluorescent RNA reporter molecule, T7 RNA polymerase, NTPmix, RNase inhibitor, and buffer.

[0011] More preferably, the sequence of the fluorescent RNA reporter molecule is 5'-FAM-UUUUUU-BHQ1-3', and the final concentration of the buffer is 30.6 mmol / L HEPES+15.3 mmol / L MgCl2 aqueous solution.

[0012] Another object of the present invention is to provide the use of the above primer set or the above kit in the preparation of avian metapneumovirus detection products.

[0013] Another object of the present invention is to provide a method for detecting avian metapneumovirus based on the CRISPR-Cas13a system, comprising the following steps:

[0014] S1: Extract RNA from the sample to be tested and reverse transcribe it into cDNA;

[0015] S2: isothermal amplification of the cDNA to be tested, with the primers being the sequences shown in SEQ ID NO.3 and SEQ ID NO.5;

[0016] S3: Detect the isothermal amplification product obtained in S2 using the CRISPR-Cas13a reaction system, where the crRNA in the CRISPR / Cas13a system is the sequence shown in SEQ ID NO.11;

[0017] S4: Result determination: the difference between the reaction endpoint fluorescence value and the starting fluorescence value of the test group and the difference between the reaction endpoint fluorescence value and the starting fluorescence value of the negative control group are subjected to biostatistical analysis. If there is a difference, the test result is positive, and if there is no difference, the test result is negative.

[0018] Preferably, the isothermal amplification system of S2 is as shown in Table 2 of the specification, and the isothermal amplification condition is 39° C. for 20 min.

[0019] Preferably, the CRISPR-Cas13a reaction system described in S3 is as shown in Table 3 of the specification, and the conditions of the CRISPR-Cas13a reaction are 37°C for 40 min.

[0020] Beneficial effects: The detection method of the present invention can specifically detect avian metapneumovirus with a sensitivity of 2 copies. It has the advantages of good specificity, high sensitivity, good repeatability, simple and rapid operation, and no reliance on professional technicians and specific instruments and equipment. It is suitable for grassroots and on-site applications, and can quickly detect avian metapneumovirus nucleic acid molecules, providing an efficient and accurate detection method for determining early infection of avian metapneumovirus in production. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.

[0022] Figure 1 This is a schematic diagram of isothermal amplification primer screening. The three rows from top to bottom are the upstream primers T71F, T72F, and T73F. The seven columns from left to right are the downstream primers 1R, 2R, 3R, 4R, 5R, 6R, and 7R.

[0023] Figure 2 This is a schematic diagram of the cross-reaction between isothermal amplification primers and crRNA primers. The 21 rows from top to bottom represent 21 isothermal amplification primer combinations, and the 4 columns from left to right represent 4 crRNAs. The darker the color block, the stronger the fluorescence signal generated after the isothermal amplification primer pair reacts with the crRNA combination.

[0024] Figure 3 This is the effect of different concentrations of LwaCas13a protein on the CRISPR-Cas13a detection reaction. The curves in the figure represent the reaction fluorescence curves when the final concentrations of LwaCas13 protein are 10nmol, 20nmol, 40nmol, 80nmol, and 160nmol.

[0025] Figure 4 This is the effect of different concentrations of crRNA on the CRISPR-Cas13a detection reaction. The curves in the figure represent the reaction fluorescence curves when the final crRNA concentrations are 10 nmol, 20 nmol, 40 nmol, 80 nmol, and 160 nmol.

[0026] Figure 5 This is the effect of different concentrations of NTP mix on the CRISPR-Cas13a detection reaction. The curves in the figure represent the reaction fluorescence curves when the final concentrations of NTP mix are 0.5mmol, 1mmol, 2mmol, 4mmol, and 8mmol.

[0027] Figure 6To show the effect of adding different amounts of T7 RNA polymerase on the CRISPR-Cas13a detection reaction, the curves in the figure represent the reaction fluorescence curves when the added amounts of T7 RNA polymerase are 0.2μL, 0.4μL, 0.6μL, 0.8μL, and 1.0μL.

[0028] Figure 7 This is the effect of different concentrations of fluorescent RNA reporter molecules on the CRISPR-Cas13a detection reaction. The curves in the figure represent the reaction fluorescence curves when the final concentrations of the fluorescent RNA reporter molecules are 10nmol, 20nmol, 40nmol, 80nmol, and 160nmol.

[0029] Figure 8 This is the effect of different temperatures on the CRISPR-Cas13a detection reaction. The curves in the figure represent the reaction fluorescence curves at temperatures of 33°C, 35°C, 37°C, 39°C, and 41°C.

[0030] Fig. 9 It is the specific identification result of the detection system of the present invention.

[0031] Fig.10 It is the sensitivity test result of the detection system of the present invention. DETAILED DESCRIPTION

[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] A method for rapid detection of avian metapneumovirus based on the CRISPR-Cas13a system, comprising the following steps:

[0034] S1: Extract RNA from the sample to be tested and reverse transcribe it into cDNA;

[0035] S2: isothermal amplification of the cDNA to be tested, with the primers being the sequences shown in SEQ ID NO.3 and SEQ ID NO.5;

[0036] S3: Detect the isothermal amplification product obtained in S2 using the CRISPR-Cas13a reaction system, where the crRNA in the CRISPR / Cas13a system is the sequence shown in SEQ ID NO.11;

[0037] S4: Result determination: the difference between the reaction endpoint fluorescence value and the starting fluorescence value of the test group and the difference between the reaction endpoint fluorescence value and the starting fluorescence value of the negative control group (using water as a template) are subjected to biostatistical analysis. If there is a difference, the test result is positive, and if there is no difference, the test result is negative.

[0038] Example 1

[0039] 1. The avian metapneumovirus genome sequence published on NCBI was compared by bioinformatics software. Three primers with T7 promoter were designed upstream of the conserved sequence obtained by comparison, named T71F, T72F, and T73F, respectively. Seven pairs of primers were designed downstream of the sequence, named 1R, 2R, 3R, 4R, 5R, 6R, and 7R, respectively. The information of upstream and downstream primers is shown in Table 1.

[0040] Table 1

[0041]

[0042]

[0043] 2. Using clinical positive samples as isothermal amplification reaction templates, extract RNA from the samples and reverse transcribe them into cDNA. Use 3 upstream primers and 7 downstream primers to cross-combine a total of 21 primer combinations for reaction. The reaction system is shown in Table 2 (using the Ampu Future Kit), and the reaction conditions are 39°C for 20 min. The results are shown in the attached Figure 1 As shown, all 21 primer combinations can amplify corresponding bands, so all of them are used to cross-react with the crRNA of the CRISPR-Cas13a system.

[0044] Table 2

[0045] Components Volume (μL) ABuffer 29.4 Upstream primer (10 μmol) 2 Downstream primer (10 μmol) 2 <![CDATA[ddH2O]]> 12.1 DNA template 2 BBuffer 2.5 Total volume 50

[0046] 3. Configure the CRISPR-Cas13a reaction system according to Table 3, mix the components and place them in the ROCHE Light Cycler 480 real-time fluorescence quantitative PCR instrument, set the reaction program to 37 ° C for 40 min, detect the fluorescence signal every 10 s, and use FAM as the detection channel.

[0047] Table 3

[0048]

[0049]

[0050] The crRNA sequence in Table 3 is shown in Table 1 (the underlined area is the repeating sequence in crRNA), the fluorescent RNA reporter molecule sequence is 5'-FAM-UUUUUU-BHQ1-3', the isothermal amplification product is obtained in step 2, and the final concentration of the buffer is 30.6mmol / LHEPES+15.3mmol / L MgCl2 aqueous solution.

[0051] The results are attached Figure 2 As shown, only crRNA1 and crRNA2 participated in the reaction with positive results, while crRNA3 and crRNA4 participated in the reaction with negative results. And the detection effect in the positive combination has significant difference, and the fluorescence signal produced by the combination of T73F+2R+crRNA1 is the strongest, so this combination is used in the kit of the present invention.

[0052] 4. The kit of the present invention includes: LwaCas13a protein (1 μmol / L), fluorescent RNA reporter molecule (10 μmol / L), crRNA (1 μmol / L), isothermal amplification upstream and downstream primers (10 μmol / L), buffer, T7 RNA polymerase (Shanghai Sangon Biotechnology Co., Ltd.), NTP mix (25 mmol / L), and RNase inhibitor (40 U / μL).

[0053] The sequence of the fluorescent RNA reporter molecule is 5'-FAM-UUUUUU-BHQ1-3'; the crRNA is crRNA1 (SEQ ID NO.11), the isothermal amplification upstream primer is T73F (SEQ ID NO.3), and the isothermal amplification downstream primer is 2R (SEQ ID NO.5); the final concentration of the buffer is 30.6 mmol / L HEPES + 15.3 mmol / L MgCl2 aqueous solution.

[0054] Kit optimization: adjust the final concentrations of LwaCas13a protein, crRNA, NTP mix, T7 RNA polymerase, and fluorescent RNA reporter molecules in the reaction system to obtain the best reaction components, and optimize the reaction temperature. The optimization results are shown in the attached Figure 3 , Attachment Figure 4 , Attachment Figure 5 , Attachment Figure 6 , Attachment Figure 7 , Attachment Figure 8As shown, the optimal reaction components are LwaCas13a protein (1 μmol / L): 2 μL, crRNA (1 μmol / L): 1 μL, fluorescent RNA reporter molecule (10 μmol / L): 1 μL, T7 RNA polymerase: 1 μL, NTPmix (25 mmol / L): 1 μL, RNase inhibitor (40 U / μL): 0.5 μL, constant temperature amplification product: 2 μL, buffer: 16.5 μL (25 μL in total).

[0055] Example 2

[0056] 1. Specificity detection

[0057] The specificity of the detection method established in Example 1 was investigated by testing positive samples of avian metapneumovirus, Newcastle disease virus, avian infectious bronchitis virus, infectious laryngotracheitis virus, infectious bursal disease virus, Marek's disease virus, avian leukosis virus, avian reovirus, Mycoplasma gallisepticum, Mycoplasma synoviae, Escherichia coli, Salmonella, and Avibacterium paragallinarum. The results are shown in the attached figure. Fig. 9 As shown, only the positive sample of avian metapneumovirus produced a fluorescent model with extremely significant difference, while the fluorescent signals of other samples had no obvious difference with the negative control.

[0058] 2. Sensitivity test

[0059] Synthesize the gene sequence of the isothermal amplification primer and connect it to the pUC-19T plasmid to prepare the positive standard plasmid. Take 2 μL of 1×10 5 -1×10 0 The positive standard plasmid with 1000 copies / μL was used as a sample and tested using the method established in Example 1, and the empty pUC-19T plasmid was used as a negative control. The results are shown in the attached figure. Fig.10 As shown in the figure, this method can detect at least 2 copies of samples.

[0060] 3. Repeatability test

[0061] From the above step, 5 positive standard plasmids and empty plasmids of different concentrations were selected for detection, and each sample was tested 3 times to evaluate the intra-batch repeatability of the detection system of the present invention. The above 6 samples were tested at three time points with an interval of 14 days to evaluate the inter-batch repeatability of the present invention. The results are shown in Tables 4 and 5. The coefficient of variation of both the intra-batch repeatability and the inter-batch repeatability is less than 10%, indicating that the present invention has good repeatability.

[0062] Table 4 Intra-batch repeatability

[0063]

[0064] Table 5. Repeatability between batches

[0065]

[0066] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.

[0067] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A primer set for detecting avian metapneumovirus based on the CRISPR-Cas13a system, characterized in that: The primer set includes a constant temperature amplification primer pair and a crRNA sequence; Furthermore, the nucleotide sequence of the isothermal amplification primer pair is shown as SEQ ID NO.3 and SEQ ID NO.5, and the nucleotide sequence of the crRNA sequence is shown as SEQ ID NO.

11.

2. A kit for detecting avian metapneumovirus based on the CRISPR-Cas13a system, characterized in that: The kit comprises the primer set according to claim 1.

3. The kit according to claim 2, characterized in that The kit also includes LwaCas13a protein, fluorescent RNA reporter molecule, T7 RNA polymerase, NTP mix, RNase inhibitor, and buffer.

4. The kit according to claim 3, characterized in that The sequence of the fluorescent RNA reporter molecule is 5'-FAM-UUUUUU-BHQ1-3', and the final concentration of the buffer is 30.6mmol / L HEPES+15.3mmol / L MgCl2 aqueous solution.

5. Use of the primer set according to claim 1 or the kit according to any one of claims 2 to 4 in the preparation of an avian metapneumovirus detection product.

6. A method for detecting avian metapneumovirus based on the CRISPR-Cas13a system, characterized in that: The following steps are involved: S1: Extract RNA from the sample to be tested and reverse transcribe it into cDNA; S2: isothermal amplification of the cDNA to be tested, with the primers being the sequences shown in SEQ ID NO.3 and SEQ ID NO.5; S3: Using the CRISPR-Cas13a reaction system to cut the isothermal amplification product obtained in S2, the crRNA in the CRISPR / Cas13a system is the sequence shown in SEQ ID NO.11; S4: Result determination: the difference between the reaction endpoint fluorescence value and the starting fluorescence value of the test group and the difference between the reaction endpoint fluorescence value and the starting fluorescence value of the negative control group are subjected to biostatistical analysis. If there is a difference, the test result is positive, and if there is no difference, the test result is negative.

7. The method according to claim 6, characterized in that The isothermal amplification system of S2 is shown in Table 2 of the specification, and the isothermal amplification condition is 39°C for 20 min.

8. The method according to claim 6, characterized in that The CRISPR-Cas13a reaction system described in S3 is shown in Table 3 of the specification, and the conditions of the CRISPR-Cas13a reaction are 37°C for 40 min.

Citation Information

Patent Citations

  • Primer for detecting metapneumovirus, metapneumovirus kit and preparation method thereof

    CN112725529A

  • Kit for detecting avian influenza virus and detection method thereof

    CN113699279A

  • Crispr-based assay for detecting pathogens in samples

    WO2021236987A2